Training program for cancer genetics and epigenetics research
Huntsman Cancer Institute (HCI) Cancer Genetics, Epigenetics, Models, and Signaling (Cancer GEMS) Training Program
['FUNDING_TRAINING'] · UNIVERSITY OF UTAH · NIH-10812353
The Cancer GEMS Training Program at the Huntsman Cancer Institute is designed to help young scientists learn about cancer by giving them hands-on lab experience and the chance to interact with patients and doctors, so they can build the skills needed for future careers in cancer research.
Quick facts
| Phase | ['FUNDING_TRAINING'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF UTAH (nih funded) |
| Locations | 1 site (SALT LAKE CITY, UNITED STATES) |
| Trial ID | NIH-10812353 on ClinicalTrials.gov |
What this research studies
The Cancer GEMS Training Program at the Huntsman Cancer Institute focuses on educating and training predoctoral candidates in cancer genetics, epigenetics, and cell signaling. This program integrates hands-on laboratory experience with interactions with cancer patients and clinicians, providing a comprehensive understanding of cancer biology. Trainees will work closely with experienced faculty and mentors to develop skills necessary for impactful careers in cancer research. The program aims to prepare young scientists for future opportunities in cancer-focused research and clinical applications.
Who could benefit from this research
Good fit: Ideal candidates for this program are graduate students pursuing careers in cancer research, particularly those interested in genetics and epigenetics.
Not a fit: Patients who are not pursuing a career in cancer research or are not graduate students may not benefit from this program.
Why it matters
Potential benefit: If successful, this research could lead to a new generation of scientists equipped to advance cancer treatment and understanding.
How similar studies have performed: Similar training programs in cancer research have shown success in developing skilled researchers, making this approach well-established.
Where this research is happening
SALT LAKE CITY, UNITED STATES
- UNIVERSITY OF UTAH — SALT LAKE CITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: AYER, DONALD E — UNIVERSITY OF UTAH
- Study coordinator: AYER, DONALD E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers